The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease

Klahr, 1988, The progression of renal disease, N Eng J Med, 318, 1657, 10.1056/NEJM198806233182505 Klahr, 1998, Angiotensin II and Gene Expression in the Kidney, Am J Kidney Dis, 31, 171, 10.1053/ajkd.1998.v31.pm9428470 Schmitz, 1997, Angiotensin II signal transduction stimulation of multiple mitogen activated protein kinase pathways, Trends Endocrinol Metab, 8, 261, 10.1016/S1043-2760(97)00101-X Warnholtz, 1999, Increased NADH-oxidase-mediated super-oxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system, Circulation, 99, 2027, 10.1161/01.CIR.99.15.2027 Li, 1996, Angiotensinogen gene activation by angiotensin II is mediated by the Rel A (Nuclear Factor-kB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes, Mol Endocrinol, 10, 252 Brasier, 1996, Mechanisms for inducible control of angiotensinogen gene transcription, Hypertension, 27, 465, 10.1161/01.HYP.27.3.465 Brasier, 1996, Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator, Hypertension, 27, 1009, 10.1161/01.HYP.27.4.1009 Morrissey, 1997, Enalapril decreases nuclear factor kB activation in the kidney with ureteral obstruction, Kidney Int, 52, 926, 10.1038/ki.1997.414 Roberts, 1988, Transforming growth factor-β, Adv Cancer Res, 51, 107, 10.1016/S0065-230X(08)60221-3 Gibbons, 1992, Vascular smooth muscle hypertrophy. Autocrine transforming growth factor β1 expression determines growth response to angiotensin II, J Clin Invest, 90, 451, 10.1172/JCI115881 Kaneto, 1993, Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ligation, Kidney Int, 44, 313, 10.1038/ki.1993.246 Munger, 1997, Latent transforming growth factor-β: structural features and mechanisms of activation, Kidney Int, 51, 1376, 10.1038/ki.1997.188 Böttinger, 1997, Biology of TGF-β in knockout and transgenic mouse models, Kidney Int, 51, 1355, 10.1038/ki.1997.185 Chua, 1997, Regulation of thrombospondin-1 production by angiotensin II in rat heart endothelial cells, Biochim Biophys Acta, 1357, 209, 10.1016/S0167-4889(97)00029-3 Kagami, 1994, Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells, J Clin Invest, 93, 2431, 10.1172/JCI117251 Sanderson, 1995, Hepatic expression of mature transforming growth factor beta-1 in transgenic mice results in multiple tissue lesions, Proc Natl Acad Sci U S A, 92, 2572, 10.1073/pnas.92.7.2572 Schnermann, 1996, Regulation of endothelin production and secretion in cultured collecting duct cells by endogenous transforming growth factor-beta, Endocrinology, 137, 5000, 10.1210/endo.137.11.8895374 Hocher, 1997, Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension, J Clin Invest, 99, 1380, 10.1172/JCI119297 Kuncio, 1991, Mechanisms of tubulointerstitial fibrosis, Kidney Int, 39, 550, 10.1038/ki.1991.63 Sharma, 1995, Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator, Diabetes, 44, 1139, 10.2337/diab.44.10.1139 Border, 1992, Transforming growth factor-β in disease: The dark side of tissue repair, J Clin Invest, 90, 1, 10.1172/JCI115821 Sharma, 1997, Increased renal production of transforming growth factor-β1 in patients with type II diabetes mellitus, Diabetes, 46, 854, 10.2337/diab.46.5.854 Shankland, 1994, Expression of transforming growth factor-β1 during diabetic renal hypertrophy, Kidney Int, 46, 430, 10.1038/ki.1994.291 Wolf, 1991, Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia, Kidney Int, 39, 401, 10.1038/ki.1991.52 Eddy, 1996, Molecular insights into renal interstitial fibrosis, J Am Soc Nephrol, 7, 2495, 10.1681/ASN.V7122495 Fogo, 1989, Evidence for the central role of glomerular growth promoters in the development of sclerosis, Semin Nephrol, 9, 329 El Nahas, 1992, Growth factors and glomerular sclerosis, Kidney Int, 41, S15 Young, 1995, Cellular events in the evolution of experimental diabetic nephropathy, Kidney Int, 47, 935, 10.1038/ki.1995.139 Nakamura, 1993, mRNA expression of growth factors in glomeruli from diabetic rats, Diabetes, 42, 450, 10.2337/diab.42.3.450 Inaba, 1996, Enhanced expression of platelet-derived growth factor- β receptor by high glucose. Involvement of platelet-derived growth factor in angiopathy, Diabetes, 45, 507, 10.2337/diab.45.4.507 Throckmorton, 1995, PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products, Kidney Int, 48, 111, 10.1038/ki.1995.274 Liu, 1996, In vivo and in vitro evidence for increased expression of HGF receptor in kidney of diabetic rats, Am J Physiol, 271, F1202 Morishita, 1997, Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes, Diabetes, 46, 138, 10.2337/diab.46.1.138 Liu, 1999, Up-regulation of hepatocyte growth factor receptor: amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure, Kidney Int, 55, 442, 10.1046/j.1523-1755.1999.00267.x Miller, 1994, Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats, Am J Physiol, F129 Liu Y: Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms Am J Physiol: (Renal Physiol 277): F624–F633, 1999 Hammerman, 1989, The growth hormone-insulin-like growth factor axis in kidney, Am J Physiol, 257, F503 Phillip, 1995, The accumulation of IGF-I in kidneys of streptozotocin-diabetic rats is not associated with elevated plasma GH or IGF-I levels, Endocrine, 3, 689, 10.1007/BF02746346 Werner, 1990, Experimental diabetes increases insulinlike growth factor I and II receptor concentration and gene expression in kidney, Diabetes, 39, 1490, 10.2337/diab.39.12.1490 Sugimoto, 1996, Increased gene expression of insulin-like growth factor-I receptor in experimental diabetic rat glomeruli, Nephron, 72, 648, 10.1159/000188954 Flyvbjerg, 1992, Octreotide administration in diabetic rats: Effects on renal hypertrophy and urinary albumin excretion, Kidney Int, 41, 805, 10.1038/ki.1992.124 Feld, 1995, Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen, Kidney Int, 48, 45, 10.1038/ki.1995.265 Blazer-Yost, 1992, Role of insulin and IGF1 receptors in proliferation of cultured renal proximal tubule cells, Biochim Biophys Acta, 113, 329, 10.1016/0167-4889(92)90055-G Egido, 1993, Role of tumor necrosis factor-a in the pathogenesis of glomerular diseases, Kidney Int, 43, S59 Baud, 1992, Tumor necrosis factor α and mesangial cells, Kidney Int, 41, 600, 10.1038/ki.1992.90 Ortiz, 1995, Involvement of tumor necrosis factor-α in the pathogenesis of experimental and human glomerulonephritis, 53 Wuthrich, 1990, MHC class II antigen presentation and tumor necrosis factor in renal tubular epithelial cells, Kidney Int, 37, 783, 10.1038/ki.1990.46 Kaneto, 1996, The expression of mRNA for tumor necrosis factor-α increases in the obstructed kidney of rats soon after unilateral ureteral ligation, Nephrology, 2, 161, 10.1111/j.1440-1797.1996.tb00082.x Wolf, 1993, TNF-α induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells, Kidney Int, 44, 795, 10.1038/ki.1993.314 Mulligan, 1993, Requirements for leukocyte adhesion molecules in nephrotoxic nephritis, J Clin Invest, 91, 577, 10.1172/JCI116237 Larrick, 1990, Cytotoxic mechanism of tumor necrosis factor-a, FASEB J, 4, 3215, 10.1096/fasebj.4.14.2172061 Laster, 1988, Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis, J Immunol, 141, 2629, 10.4049/jimmunol.141.8.2629 Itoh, 1991, The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell, 66, 233, 10.1016/0092-8674(91)90614-5 Baeurle, 1994, Function and activation of NF-kB in the immune system, Annu Rev Immunol, 12, 141, 10.1146/annurev.iy.12.040194.001041 Barnes, 1997, Nuclear factor-k: a pivotal transcription factor in chronic inflammatory diseases, N Engl J Med, 336, 1066, 10.1056/NEJM199704103361506 Wendt, 1995, Tissue factor expression in an animal model of hydronephrosis, Nephrol Dial Transplant, 10, 1820 Lentsch, 1997, In vivo suppression of NF-kB and preservation of IkBα by interleukin-10 and interleukin-13, J Clin Invest, 100, 2443, 10.1172/JCI119786 Mizra A, Liu S-L, Frizell E, Zhu J, Maddukuri S, Martinez J, Davies P, Schwarting R, Norton P, Zern MA: A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kB Am J Physiol 272 (Gastrointest Liver Physiol 35):G281–G288, 1997 Butler, 1989, The nature and significance of osteopontin, Connective Tissue Res, 23, 123, 10.3109/03008208909002412 Pichler, 1994, Tubulointerstitial disease in glomerulonephritis; potential role of osteopontin (uropontin), Am J Pathol, 144, 915 Johnson, 1997, The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis, J Clin Invest, 99, 2950, 10.1172/JCI119490 Lee, 1995, Activation of hepatic stellate cells by TGF-a and collagen type I is mediated by oxidative stress through c-myb expression, J Clin Invest, 96, 2461, 10.1172/JCI118304 Nagle, 1976, Proliferation of renal interstitial cells following injury induced by ureteral obstruction, Lab Invest, 35, 18 Pedagogos, 1997, Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy, Am J Kidney Dis, 29, 912, 10.1016/S0272-6386(97)90466-2 Strutz, 1995, Identification and characterization of a fibroblast marker: FSP1, J Cell Biol, 130, 393, 10.1083/jcb.130.2.393 Tulchinsky, 1997, A k-B-related binding site is an integral part of the mts1 gene composite enhancer element located in the first intron of the gene, J Biol Chem, 272, 4828, 10.1074/jbc.272.8.4828 Morrissey, 1996, Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy, J Am Soc Nephrol, 10, 2202, 10.1681/ASN.V7102202